Consulting Services
For Investors
Products
Case Studies
Insights
BioPharma and Tech News

Contact Us

Search

chronic spontaneous urticaria

Immunology

Immunology Today—April 15, 2026

This week’s Immunology update highlights regulatory progress, clinical…

Immunology

Immunology Today—March 4, 2026

This week's Immunology update covers key regulatory actions, clinical trial…

Immunology

Immunology Video Recap—February 25, 2026

This biweekly Immunology video recap highlights key developments across…

Immunology

Immunology Today—February 18, 2026

This week's Immunology update summarizes key developments in clinical trials,…

Immunology

Immunology Today—January 8, 2026

This Immunology update captures a broad range of developments, including…

Immunology

Immunology Video Recap—December 3, 2025

This biweekly immunology video highlights major regulatory wins, evolving…

Immunology

Immunology Today—November 26, 2025

This week’s Immunology update spotlights key developments, regulatory…

Categories

Obesity News
Endocrinology News
Our Insights
Immunology News
Case studies
Hematology News
BioPharma and Tech News
Oncology News
BioPharma Strategy, CI and AI Guides
Lucid Diligence Brief
Conference Social Media Reports
Venture Capital Trends
AI in Healthcare and Digital Health
Conference Previews
Cell and Gene Therapy News
Healthcare and Pharma Trends
Rare Disease News
Health Mobile Apps Reports
Neuroscience News
Women's Health News
Public Health News
Respiratory News
Cardiovascular News
Vaccine news

Recent Posts

Cardiovascular Today—April 16, 2026
Rare Diseases Today—April 16, 2026
Cell and Gene Therapy Today—April 16, 2026
Vaccines Today—April 10, 2026
Lucid Diligence Brief: Beeline Medicines debuts with $300M Series A

Tags

AACR 2025 AHA Go Red ANAVEX 3-71 Avenzo Therapeutics Bofanglutide bone marrow failure chronic spontaneous urticaria dual incretins endocrine resistance endoluminal robotics enzyme replacement Fertility issues FreeStyle Libre 3 gestational trophoblastic tumors GLP-1 combinations graphene devices Hippo pathway IL-6 Inherited retinal diseases Innate Pharma Lassa fever mitral TEER monash Non-muscle invasive bladder cancer Osqay Partners Health Management pharma R&D plasma-derived therapies Rare endocrine disorders Recor Medical Rocket Pharmaceuticals Secukinumab self.co sexual health Sweden SWOG syndax pharmaceuticals Taho Pharmaceuticals talkspace Theramex TSHA-102 Vitiligo vre infection Wandercraft Zealand Pharma

Archives

Archives

LucidQuest Ventures

Accelerate Your Success

LATEST NEWS

Cardiovascular Today—April 16, 2026
Rare Diseases Today—April 16, 2026
Cell and Gene Therapy Today—April 16, 2026
Vaccines Today—April 10, 2026
Lucid Diligence Brief: Beeline Medicines debuts with $300M Series A

TAGS

AACR 2025 AHA Go Red ANAVEX 3-71 Avenzo Therapeutics Bofanglutide bone marrow failure chronic spontaneous urticaria dual incretins endocrine resistance endoluminal robotics enzyme replacement Fertility issues FreeStyle Libre 3 gestational trophoblastic tumors GLP-1 combinations graphene devices Hippo pathway IL-6 Inherited retinal diseases Innate Pharma Lassa fever mitral TEER monash Non-muscle invasive bladder cancer Osqay Partners Health Management pharma R&D plasma-derived therapies Rare endocrine disorders Recor Medical Rocket Pharmaceuticals Secukinumab self.co sexual health Sweden SWOG syndax pharmaceuticals Taho Pharmaceuticals talkspace Theramex TSHA-102 Vitiligo vre infection Wandercraft Zealand Pharma

Consulting Services
For Investors
Products
Case Studies
Insights
BioPharma and Tech News

© 2026 LucidQuest Ventures. All rights reserved

We use cookies from third party services to offer you a better experience. Read about how we use cookies and how you can control them by clicking "Privacy Preferences".

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required

You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.

Privacy Policy